DDI Exposures by Service Line Diagnosis
| . | % Discharges With DDI . | Most Common DDI . |
|---|---|---|
| Medical service line . | . | . |
| Solid organ transplant | 62.11 | Nicardipine and tacrolimus |
| Bone marrow transplant | 17.98 | Nicardipine and tacrolimus |
| Nephrology and urology | 4.86 | Nicardipine and tacrolimus |
| Rehabilitation | 4.56 | Nicardipine and tacrolimus |
| Hepatobiliary | 3.40 | Nicardipine and tacrolimus |
| Neonates with ECMO or major prognosis | 2.24 | Fentanyl and linezolid |
| Mental health | 1.79 | Haloperidol and quetiapine |
| Substance abuse | 1.61 | Haloperidol and quetiapine |
| Oncology | 1.29 | Methotrexate and sulfamethoxazole/trimethoprim |
| Cardiovascular | 1.18 | Nicardipine and tacrolimus |
| Surgical service line | ||
| Craniofacial and/or plastic | 15.23 | Fentanyl and linezolid |
| Nephrology and/or urology | 4.31 | Fentanyl and linezolid |
| Other trauma | 3.77 | Fentanyl and linezolid |
| Infectious disease | 3.12 | Fentanyl and linezolid |
| Oncology | 2.20 | Methotrexate and sulfamethoxazole/trimethoprim |
| Interventional and EP | 1.76 | Nicardipine and tacrolimus |
| Cardiothoracic | 1.48 | Furosemide and risperidone |
| Otolaryngology l | 1.47 | Fentanyl and linezolid |
| Other surgical | 1.34 | Fentanyl and linezolid |
| Mental health | 1.21 | Amitriptyline and sertraline |
| Respiratory | 1.14 | Fentanyl and linezolid |
| . | % Discharges With DDI . | Most Common DDI . |
|---|---|---|
| Medical service line . | . | . |
| Solid organ transplant | 62.11 | Nicardipine and tacrolimus |
| Bone marrow transplant | 17.98 | Nicardipine and tacrolimus |
| Nephrology and urology | 4.86 | Nicardipine and tacrolimus |
| Rehabilitation | 4.56 | Nicardipine and tacrolimus |
| Hepatobiliary | 3.40 | Nicardipine and tacrolimus |
| Neonates with ECMO or major prognosis | 2.24 | Fentanyl and linezolid |
| Mental health | 1.79 | Haloperidol and quetiapine |
| Substance abuse | 1.61 | Haloperidol and quetiapine |
| Oncology | 1.29 | Methotrexate and sulfamethoxazole/trimethoprim |
| Cardiovascular | 1.18 | Nicardipine and tacrolimus |
| Surgical service line | ||
| Craniofacial and/or plastic | 15.23 | Fentanyl and linezolid |
| Nephrology and/or urology | 4.31 | Fentanyl and linezolid |
| Other trauma | 3.77 | Fentanyl and linezolid |
| Infectious disease | 3.12 | Fentanyl and linezolid |
| Oncology | 2.20 | Methotrexate and sulfamethoxazole/trimethoprim |
| Interventional and EP | 1.76 | Nicardipine and tacrolimus |
| Cardiothoracic | 1.48 | Furosemide and risperidone |
| Otolaryngology l | 1.47 | Fentanyl and linezolid |
| Other surgical | 1.34 | Fentanyl and linezolid |
| Mental health | 1.21 | Amitriptyline and sertraline |
| Respiratory | 1.14 | Fentanyl and linezolid |
Only service lines with percent of discharges with a DDI >1.0 are reported. ECMO, extracorporeal membrane oxygenation; EP, electrophysiology.